COMT and Parkinson disease: Inhibitors for COMT are thus used to treat Parkinson’s disease together with the dopamine precursor L–DOPA [645,646]; the goal is to prevent dopamine deficiency in neurons, and the role of COMT inhibitors is to avoid L–DOPA degradation before it is converted to dopamine.